Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fanconi syndrome after ifosfamide.

Literature DB >> 2910509

Fanconi syndrome after ifosfamide.

Abstract

A 2-year-old boy developed the Fanconi syndrome 1 year after being treated successfully for a neuroblastoma. This is probably an unusual complication of ifosfamide.

Entities: Chemical Disease Species

Mesh：

Substances：
Ifosfamide

Year: 1989 PMID： 2910509 DOI： 10.1007/BF00273531

Source DB: PubMed Journal: Cancer Chemother Pharmacol ISSN： 0344-5704 Impact factor: 3.333

6 in total

1. Gentamicin: toxicity in perspective.

Authors: W L Hewitt
Journal: Postgrad Med J Date: 1974-11 Impact factor: 2.401

2. Renal dysfunction after treatment with isophosphamide (NSC-109724).

Authors: R A DeFronzo; M Abeloff; H Braine; R L Humphrey; P J Davis
Journal: Cancer Chemother Rep Date: 1974 May-Jun

Review 3. Ifosfamide--pharmacology, safety and therapeutic potential.

Authors: W P Brade; K Herdrich; M Varini
Journal: Cancer Treat Rev Date: 1985-03 Impact factor: 12.111

4. Renal toxicity of cisplatin in children.

Authors: R B Womer; J Pritchard; T M Barratt
Journal: J Pediatr Date: 1985-04 Impact factor: 4.406

5. Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.

Authors: G Sangster; S B Kaye; K C Calman; J F Dalton
Journal: Eur J Cancer Clin Oncol Date: 1984-03

6. Case of tumour rickets.

Authors: M W Moncrieff; D P Brenton; L J Arthur
Journal: Arch Dis Child Date: 1978-09 Impact factor: 3.791

6 in total

16 in total

Review 1. Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors: K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal: Drugs Date: 1991-09 Impact factor: 9.546

Fanconi syndrome after ifosfamide.

1. Gentamicin: toxicity in perspective.

2. Renal dysfunction after treatment with isophosphamide (NSC-109724).

Review 3. Ifosfamide--pharmacology, safety and therapeutic potential.

4. Renal toxicity of cisplatin in children.

5. Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.

6. Case of tumour rickets.

Review 1. Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Review 2. Genitourinary long-term outcomes for childhood cancer survivors.

3. Iphosphamide-induced nephrotoxicity in children.

4. Tubular nephrotoxicity during long-term ifosfamide and mesna therapy.

Review 5. Renal toxicity and chemotherapy in children with cancer.

Review 6. Cytostatics--induced tubular toxicity.

7. Partial and complete de Toni-Debré-Fanconi syndrome after ifosfamide chemotherapy of childhood malignancy.

8. Urinary excretion of the enantiomers of ifosfamide and its inactive metabolites in children.

Review 9. Dosing and side-effects of ifosfamide plus mesna.

10. Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases.